HOUSE-BILL 5158: H.R.5158 - Fair Price Device Act
AI-Powered Summary
HOUSE-BILL 5158 aims to enhance access to combination products that include generic drugs and medical devices by amending the approval process for these items. The legislation addresses major themes of healthcare access, affordability, and regulatory oversight, particularly emphasizing the right to access safe and effective medications and devices under the broader context of individual rights and public health. Key provisions include ensuring that new drugs used with devices maintain the same clinical effect and safety profile as existing drugs, mandating comprehensive information on compatibility and performance, and promoting increased access to generic options to lower consumer costs. Implementation requirements involve regulatory adjustments by federal agencies in accordance with the Administrative Procedure Act, although specific timelines for these changes are not detailed in the bill. The potential impacts include improved access to affordable healthcare options for patients, although there are constitutional concerns regarding the safety and efficacy standards of drugs and devices that could arise from these amendments.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill's provisions could lead to disparities in access to safe and effective medical products, particularly affecting marginalized groups. This raises constitutional concerns about equal protection and the right to health care, which, while not explicitly guaranteed, is often interpreted as a fundamental aspect of individual rights.
Key Individual Rights Affected
- Right to Health Care
- Equal Protection under the Law
- Due Process
Constitutional Provisions
- Fourteenth Amendment - Equal Protection Clause
- Fifth Amendment - Due Process Clause
Potential Constitutional Challenges
The bill may face challenges if it is perceived to disproportionately affect certain demographic groups, such as infants, seniors, and low-income individuals, by compromising their access to safe medical products. Additionally, if the approval process is expedited without adequate safety evaluations, it could lead to legal challenges based on due process concerns.
Summary
HOUSE-BILL 5158 has the potential to significantly impact individuals' access to essential medical products, particularly for vulnerable populations. While it aims to increase access and reduce costs, the implications for safety and efficacy standards raise serious constitutional concerns regarding individual rights and equal protection under the law. The bill's effects will vary across demographic groups, with particular attention needed for those who may be disproportionately affected.
Constitutional Analysis
This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 5158 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
September 4, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat